HHS Logo U.S. Department of Health & Human Services Divider arrowNIH logo National Institutes of Health Alt desc
Skip Over Navigation Links
Doctor examining small child being held by her mother.

New Funding Opportunities to Repurpose Drugs

NCATS has announced funding opportunities to repurpose existing drugs through public-private partnerships.

Work with Us

Learn more about how you can access funding and collaborate with the New Therapeutic Uses program.

Contact Christine Colvis, Ph.D.

Discovering New Therapeutic Uses for Existing Molecules

Through its Discovering New Therapeutic Uses for Existing Molecules (New Therapeutic Uses) program, NCATS aims to improve the process of developing new treatments and cures for disease by finding new uses for existing therapies that already have cleared several key steps along the development path. This also is known as drug repurposing. Learn more about New Therapeutic Uses.

Find NCATS Programs & InitiativesAccess NCATS Expertise & Resources

    New Therapeutic Uses and Drug Repurposing

    Therapeutic development is a costly, complex and time-consuming process. The average length of time from target discovery to approval of a new drug is about 14 years. The failure rate during this process exceeds 95 percent, and the cost per successful drug can be $1 billion or more. The high therapeutic development failure rate means there are many existing, partially developed therapeutic candidates that could be repurposed for use in new disease indications. Bringing together the best assets from pharmaceutical companies with the best new ideas from academic researchers could produce new treatments much more quickly than starting from scratch. Learn more about the purpose of the New Therapeutic Uses program.